Utilidad del óxido nítrico inhalado en paciente con síndrome de distrés respiratorio agudo y tetralogía de Fallot no intervenida
Medicina Intensiva, ISSN: 0210-5691, Vol: 30, Issue: 1, Page: 23-25
2006
- 12Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
La utilidad del óxido nítrico inhalado en el tratamiento del síndrome de distrés respiratorio agudo (SDRA) con hipertensión pulmonar (HPP) es controvertida y hay pocos estudios en la literatura que evalúen sus efectos durante una administración prolongada. Analizamos el caso de un paciente de 45 días de vida con tetralogía de Fallot no intervenida, que desarrolló SDRA e HPP de causa no cardíaca, que precisó ventilación mecánica prolongada (30 días) y administración de óxido nítrico inhalado (ONI). Antes del ONI el índice de oxigenación era 19 y a los pocos minutos de su aplicación descendió a 15. El paciente desarrolló dependencia del ONI, tolerando un destete gradual, pudiendo interrumpir la administración a los 27 días de su inicio. No observamos efectos tóxicos durante la administración del ONI.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0210569106744588; http://dx.doi.org/10.1016/s0210-5691(06)74458-8; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=33644785879&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/16637428; http://linkinghub.elsevier.com/retrieve/pii/S0210569106744588; http://api.elsevier.com/content/article/PII:S0210569106744588?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0210569106744588?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S0210569106744588; http://dx.doi.org/10.1016/s0210-5691%2806%2974458-8; https://dx.doi.org/10.1016/s0210-5691%2806%2974458-8
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know